z-logo
open-access-imgOpen Access
Non-small cell lung cancer with the tracheal bifurcation involvement. Carinal pneumonectomy or chemo-radiation therapy?
Author(s) -
I A Dadyev,
Дадыев Ислам Артурович,
М. М. Давыдов,
Давыдов Михаил Михайлович,
M. S. Shogenov,
Шогенов Мурат Сергеевич,
А. Г. Абдуллаев,
Абдуллаев Амир Гусейнович,
Maksat A. Ibraev,
Ибраев Максат Асанович,
A. A. Filatov,
Филатов Антон Александрович
Publication year - 2018
Publication title -
sovremennaâ onkologiâ
Language(s) - English
Resource type - Journals
eISSN - 1815-1442
pISSN - 1815-1434
DOI - 10.26442/18151434.2018.4.180161
Subject(s) - medicine , pneumonectomy , radiation therapy , surgery , complication , lung cancer , survival rate
The aim of the study: the aim of this study was to compare the immediate and long-term results of treatment of patients with non-small cell lung cancer with involvement of tracheal bifurcation, which were underwent pneumonectomy with resection of the tracheal bifurcation or radical chemo-radiation therapy (CRT). Materials and methods. We conducted a retrospective non-randomized clinical study with following groups of patients: 1) 65 patients who underwent pneumonectomy with resection of the tracheal bifurcation; 2) 30 patients to whom CRT was performed. Evaluation of the effectiveness of immediate and long-term results was carried out by statistical processing using the Statistic 6.0 program. A case-control analysis was performed to compare two groups. The time of the operation, intra- and postoperative complications was estimated depending on the type of resection of the tracheal bifurcation. Results. The complication rate was 46.1% in the surgical group. In the CRT group complications developed in 13 (43.3%) patients. The overall 1-, 3-, 5-year survival rate in the group of patients with surgical treatment was 56.92, 31.7 and 26.1%, respectively. The median overall survival was 14.5 months. Indicators of 1-, 3-, and 5-year survival in the group of patients who underwent radical CRT were 31.6, 24.4, 16.2%.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here